Company / R&D per Share
Intuitive Surgical R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.68
FY2025
5-year range
$1.58 / $3.68
FY2021-FY2025
Trend
+13.2%
vs FY2024
Sector context
#15 of 108
Health Care
What the data says
Intuitive Surgical's r&d per share of $3.68 is higher than 86% of companies in the Health Care sector (FY2025). R&D per Share has increased for 4 consecutive years, from $1.58 in FY2021 to $3.68 in FY2025.
Based on SEC 10-K filings.
3.68 in FY2025 with a 5-year CAGR of +0.4%. Top quartile in the Health Care sector.
Improved from $1.92 to $3.68 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +30.3%
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 108This company $3.68 Sector average $2.07
▼
+77.7% above sector average
Key checks
Key Insights
- Intuitive Surgical's r&d per share has grown for 4 consecutive years.
- In FY2025, r&d per share increased 13.2% year-over-year.
- Ranks #15 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.34 (safe zone, above 2.9 threshold)
- Strong profit margin: 28.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.68 | +13.2% |
| FY2024 | $3.25 | +69.6% |
| FY2023 | $1.92 | +15.2% |
| FY2022 | $1.66 | +5.4% |
| FY2021 | $1.58 | -56.2% |
| FY2020 | $3.60 | +25.6% |
| FY2019 | $2.87 | +34.5% |
| FY2018 | $2.13 | -24.4% |
| FY2017 | $2.82 | -40.7% |
| FY2016 | $4.76 | -11.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026